nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A pledge for planetary health to unite health professionals in the Anthropocene
|
Wabnitz, Katharina-Jaqueline |
|
|
396 |
10261 |
p. 1471-1473 |
artikel |
2 |
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
|
Chauhan, Anil |
|
|
396 |
10261 |
p. 1485-1486 |
artikel |
3 |
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
|
Lodge, Archie |
|
|
396 |
10261 |
p. 1486 |
artikel |
4 |
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply
|
Voysey, Merryn |
|
|
396 |
10261 |
p. 1486-1487 |
artikel |
5 |
Clinical trial reporting
|
Gao, Liang |
|
|
396 |
10261 |
p. 1488-1489 |
artikel |
6 |
Clinical trial reporting
|
Ulug, Pinar |
|
|
396 |
10261 |
p. 1489 |
artikel |
7 |
Clinical trial reporting – Authors' reply
|
DeVito, Nicholas J |
|
|
396 |
10261 |
p. 1489-1490 |
artikel |
8 |
COVID-19 in Latin America: a humanitarian crisis
|
The Lancet, |
|
|
396 |
10261 |
p. 1463 |
artikel |
9 |
Department of Error
|
|
|
|
396 |
10261 |
p. 1490 |
artikel |
10 |
Department of Error
|
|
|
|
396 |
10261 |
p. 1490 |
artikel |
11 |
Early triple antiviral therapy for COVID-19
|
Lee, Nelson |
|
|
396 |
10261 |
p. 1487-1488 |
artikel |
12 |
Early triple antiviral therapy for COVID-19 – Authors' reply
|
Hung, Ivan Fan-Ngai |
|
|
396 |
10261 |
p. 1488 |
artikel |
13 |
Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials
|
Ward, Brian J |
|
|
396 |
10261 |
p. 1491-1503 |
artikel |
14 |
Enabling a healthy start for vulnerable newborns
|
Stock, Sarah J |
|
|
396 |
10261 |
p. 1490 |
artikel |
15 |
First human efficacy study of a plant-derived influenza vaccine
|
Tregoning, John S |
|
|
396 |
10261 |
p. 1464-1465 |
artikel |
16 |
Global growth trends in school-aged children and adolescents
|
Sawyer, Susan M |
|
|
396 |
10261 |
p. 1465-1467 |
artikel |
17 |
Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants
|
|
|
|
396 |
10261 |
p. 1511-1524 |
artikel |
18 |
Ice pack test in myasthenia gravis: a cool investigation at the bedside
|
Dias, Leonor |
|
|
396 |
10261 |
p. e82 |
artikel |
19 |
Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe
|
Han, Emeline |
|
|
396 |
10261 |
p. 1525-1534 |
artikel |
20 |
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial
|
Jeger, Raban V |
|
|
396 |
10261 |
p. 1504-1510 |
artikel |
21 |
More than medical mistrust
|
Manning, Kimberly D |
|
|
396 |
10261 |
p. 1481-1482 |
artikel |
22 |
More than meets the AI: refining image acquisition and resolution
|
Harvey, Hugh |
|
|
396 |
10261 |
p. 1479 |
artikel |
23 |
New Zealanders approve euthanasia in landmark vote
|
Kirby, Tony |
|
|
396 |
10261 |
p. 1478 |
artikel |
24 |
Offline: Managing the COVID-19 vaccine infodemic
|
Horton, Richard |
|
|
396 |
10261 |
p. 1474 |
artikel |
25 |
Peter Sleight
|
Yusuf, Salim |
|
|
396 |
10261 |
p. 1483 |
artikel |
26 |
Report released on Women Deliver allegations
|
Burki, Talha |
|
|
396 |
10261 |
p. 1477 |
artikel |
27 |
Roopa Dhatt: advancing gender equality in global health leadership
|
Prasad, Aarathi |
|
|
396 |
10261 |
p. 1480 |
artikel |
28 |
SARS-CoV-2 seroprevalence in Spain
|
Hoffmann, Christian |
|
|
396 |
10261 |
p. 1484 |
artikel |
29 |
SARS-CoV-2 seroprevalence in Spain
|
George, Thukalan Paulose |
|
|
396 |
10261 |
p. 1484 |
artikel |
30 |
SARS-CoV-2 seroprevalence in Spain – Authors' reply
|
Pollán, Marina |
|
|
396 |
10261 |
p. 1484-1485 |
artikel |
31 |
Strategy, coordinated implementation, and sustainable financing needed for COVID-19 innovations
|
Dzau, Victor J |
|
|
396 |
10261 |
p. 1469-1471 |
artikel |
32 |
Surgery during the COVID-19 pandemic
|
Alderman, Joseph |
|
|
396 |
10261 |
p. e76 |
artikel |
33 |
Surgery during the COVID-19 pandemic
|
Vuthaluru, Seenu |
|
|
396 |
10261 |
p. e78 |
artikel |
34 |
Surgery during the COVID-19 pandemic
|
Hamid, Hytham K S |
|
|
396 |
10261 |
p. e73 |
artikel |
35 |
Surgery during the COVID-19 pandemic
|
Shanthanna, Harsha |
|
|
396 |
10261 |
p. e74 |
artikel |
36 |
Surgery during the COVID-19 pandemic
|
Meecham, Lewis |
|
|
396 |
10261 |
p. e77 |
artikel |
37 |
Surgery during the COVID-19 pandemic
|
Rodrigues, Jeremy |
|
|
396 |
10261 |
p. e75 |
artikel |
38 |
Surgery during the COVID-19 pandemic – Authors' reply
|
COVIDSurg Collaborative, |
|
|
396 |
10261 |
p. e79 |
artikel |
39 |
The need for gambling disorder clinics in Wales
|
Dymond, Simon |
|
|
396 |
10261 |
p. e80 |
artikel |
40 |
Turkish Medical Association clashes with politicians
|
Genç, Kaya |
|
|
396 |
10261 |
p. 1475-1476 |
artikel |
41 |
US racial and ethnic data for COVID-19 cases: still missing in action
|
Krieger, Nancy |
|
|
396 |
10261 |
p. e81 |
artikel |
42 |
What can we expect from first-generation COVID-19 vaccines?
|
Peiris, Malik |
|
|
396 |
10261 |
p. 1467-1469 |
artikel |